Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

Event Details

Agios at 39th Annual J.P. Morgan Healthcare Conference

Jan 11, 2021 at 10:50 AM EST

Webcast Presentation

Supporting Materials

Title
Agios at 39th Annual J.P. Morgan Healthcare Conference
Date / Time
Jan 11, 2021 at 10:50 AM EST